Last reviewed · How we verify
RENESSANS
RENESSANS is a medication used to treat atrial fibrillation.
RENESSANS is a medication used to treat atrial fibrillation. Used for Symptomatic paroxysmal atrial fibrillation, Symptomatic persistent atrial fibrillation.
At a glance
| Generic name | RENESSANS |
|---|---|
| Also known as | IODINE POLYMER |
| Sponsor | MTI Medical Private Limited, Pakistan |
| Drug class | Antiarrhythmic |
| Target | Unknown |
| Modality | Biologic |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
It works by converting atrial fibrillation to sinus rhythm. RENESSANS is used in patients with symptomatic paroxysmal or persistent atrial fibrillation. It is administered via intravenous infusion.
Approved indications
- Symptomatic paroxysmal atrial fibrillation
- Symptomatic persistent atrial fibrillation
Common side effects
- Hypotension
- Bradycardia
- Nausea
- Vomiting
- Headache
- Dizziness
- Fatigue
- Diarrhea
- Abdominal pain
- Chest pain
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RENESSANS CI brief — competitive landscape report
- RENESSANS updates RSS · CI watch RSS
- MTI Medical Private Limited, Pakistan portfolio CI